Selected article for: "absolute lymphocyte and neutrophil count"
Author: Cihakova, Daniela; Streiff, Michael B; Menez, Steven P; Chen, Teresa K; Gilotra, Nisha A; Michos, Erin D; Marr, Kieren A; Karaba, Andrew H; Robinson, Matthew L; Blair, Paul W; Dioverti, Maria V; Post, Wendy S; Cox, Andrea L; R Antar, Annukka A
Title: High-value laboratory testing for hospitalized COVID-19 patients: a review
  • Cord-id: qf1dqgsl
  • Document date: 2021_9_21
    • ID: qf1dqgsl
    Snippet: We present here an evidence-based review of the utility, timing, and indications for laboratory test use in the domains of inflammation, cardiology, hematology, nephrology and co-infection for clinicians managing the care of hospitalized COVID-19 patients. Levels of IL-6, CRP, absolute lymphocyte count, neutrophils and neutrophil-to-lymphocyte ratio obtained upon admission may help predict the severity of COVID-19. Elevated LDH, ferritin, AST, and d-dimer are associated with severe illness and m
    Document: We present here an evidence-based review of the utility, timing, and indications for laboratory test use in the domains of inflammation, cardiology, hematology, nephrology and co-infection for clinicians managing the care of hospitalized COVID-19 patients. Levels of IL-6, CRP, absolute lymphocyte count, neutrophils and neutrophil-to-lymphocyte ratio obtained upon admission may help predict the severity of COVID-19. Elevated LDH, ferritin, AST, and d-dimer are associated with severe illness and mortality. Elevated cardiac troponin at hospital admission can alert clinicians to patients at risk for cardiac complications. Elevated proBNP may help distinguish a cardiac complication from noncardiac etiologies. Evaluation for co-infection is typically unnecessary in nonsevere cases but is essential in severe COVID-19, intensive care unit patients, and immunocompromised patients.

    Search related documents:
    Co phrase search for related documents
    • acute phase and additional evaluation: 1, 2
    • acute phase and additional evidence: 1
    • acute phase and admission patient: 1, 2, 3
    • acute phase and admission present: 1, 2
    • acute phase and liver failure: 1, 2, 3, 4, 5
    • acute phase and liver function: 1, 2, 3, 4, 5, 6, 7
    • acute phase and long term management: 1, 2, 3, 4, 5, 6
    • acute phase and low incidence: 1, 2
    • acute phase and low molecular weight: 1, 2, 3, 4, 5, 6, 7
    • acute phase and low molecular weight heparin: 1, 2, 3, 4, 5, 6
    • acute phase and low specificity: 1, 2, 3
    • acute phase and lung transplant: 1, 2, 3, 4, 5
    • acute phase and lymphocyte count: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute phase and lymphocyte neutrophil: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • acute phase and lymphocyte neutrophil ratio: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute phase and lymphocyte ratio: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15
    • acute phase and lymphocyte subset: 1, 2, 3
    • acute phase and macrophage activation: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute phase and macrophage activation syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10